Zetterberg H - Search Results

1

Publisher Correction: Microglial activation and tau propagate jointly across Braak stages.

Pascoal TA, Benedet AL, Ashton NJ, Kang MS, Therriault J, Chamoun M, Savard M, Lussier FZ, Tissot C, Karikari TK, Ottoy J, Mathotaarachchi S, Stevenson J, Massarweh G, Schöll M, de Leon MJ, Soucy JP, Edison P, Blennow K, Zetterberg H, Gauthier S, Rosa-Neto P. Pascoal TA, et al. Among authors: zetterberg h. Nat Med. 2021 Nov;27(11):2048-2049. doi: 10.1038/s41591-021-01568-3. Nat Med. 2021. PMID: 34654920 No abstract available.

2

Cerebrospinal fluid markers for prediction of Alzheimer's disease.

Zetterberg H, Wahlund LO, Blennow K. Zetterberg H, et al. Neurosci Lett. 2003 Nov 27;352(1):67-9. doi: 10.1016/j.neulet.2003.08.011. Neurosci Lett. 2003. PMID: 14615052

3

Increased cerebrospinal fluid levels of transforming growth factor-beta1 in Alzheimer's disease.

Zetterberg H, Andreasen N, Blennow K. Zetterberg H, et al. Neurosci Lett. 2004 Sep 2;367(2):194-6. doi: 10.1016/j.neulet.2004.06.001. Neurosci Lett. 2004. PMID: 15331151

4

Elevated total tau/phospho-tau ratio in autopsy-proven Creutzfeldt-Jakob disease with negative 14-3-3 test results.

Zetterberg H, Blennow K. Zetterberg H, et al. Neurol Sci. 2004 Dec;25(5):301-2. doi: 10.1007/s10072-004-0358-5. Neurol Sci. 2004. PMID: 15624089 No abstract available.

5

Diagnostic value of 14-3-3beta immunoblot and T-tau/P-tau ratio in clinically suspected Creutzfeldt-Jakob disease.

Blennow K, Johansson A, Zetterberg H. Blennow K, et al. Among authors: zetterberg h. Int J Mol Med. 2005 Dec;16(6):1147-9. Int J Mol Med. 2005. PMID: 16273298

6

Determination of beta-amyloid peptide signatures in cerebrospinal fluid using immunoprecipitation-mass spectrometry.

Portelius E, Westman-Brinkmalm A, Zetterberg H, Blennow K. Portelius E, et al. Among authors: zetterberg h. J Proteome Res. 2006 Apr;5(4):1010-6. doi: 10.1021/pr050475v. J Proteome Res. 2006. PMID: 16602710

7

Pinpointing plaques with PIB.

Blennow K, Zetterberg H. Blennow K, et al. Among authors: zetterberg h. Nat Med. 2006 Jul;12(7):753-4; discussion 754. doi: 10.1038/nm0706-753. Nat Med. 2006. PMID: 16829927 No abstract available.

8

Plasma Abeta in Alzheimer's disease--up or down?

Zetterberg H, Blennow K. Zetterberg H, et al. Lancet Neurol. 2006 Aug;5(8):638-9. doi: 10.1016/S1474-4422(06)70503-8. Lancet Neurol. 2006. PMID: 16857565 No abstract available.

9

Alzheimer's disease.

Blennow K, de Leon MJ, Zetterberg H. Blennow K, et al. Among authors: zetterberg h. Lancet. 2006 Jul 29;368(9533):387-403. doi: 10.1016/S0140-6736(06)69113-7. Lancet. 2006. PMID: 16876668 Review.

10

TAU haplotype and the Saitohin Q7R gene polymorphism do not influence CSF Tau in Alzheimer's disease and are not associated with frontotemporal dementia or Parkinson's disease.

Johansson A, Zetterberg H, Håkansson A, Nissbrandt H, Blennow K. Johansson A, et al. Among authors: zetterberg h. Neurodegener Dis. 2005;2(1):28-35. doi: 10.1159/000086428. Neurodegener Dis. 2005. PMID: 16909000

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,411 results

Search Page

Filters